Tumorad-arkiv - BioStock

Spago Nanomedical's SAB on the potential of Tumorad

Spago Nanomedical’s SAB on Tumorad’s potential

29 June, 2023

Spago Nanomedical's CDO comments on the study submission

Spago Nanomedical’s CDO on study submission

30 May, 2023

Tumorad clinical phase I/II start around the corner for

Tumorad clinical start around the corner for Spago Nanomedical

16 May, 2023

Spago Nanomedical reports advancement

Spago Nanomedical reports advancement

8 February, 2023

Spago Nanomedical publishes positive preclinical data

Spago Nanomedical publishes positive preclinical data

12 January, 2023

Spago Nanomedical starts phase IIa study in endometriosis

Spago Nanomedical starts phase IIa study in endometriosis

6 December, 2022

Spago Nanomedical in hot area

Spago Nanomedical in hot biotech area

13 September, 2022

Spago Nanomedical on the autumn newsflow

Spago Nanomedical on the autumn newsflow

26 August, 2022

Spago Nanomedical progressestowards clinical phase with Tumorad

Spago Nanomedical progresses towards clinical phase with Tumorad

5 July, 2022

Spago Nanomedical on project potential

Spago Nanomedical on project potential

3 May, 2022

12 Page 1 of 2